Suchergebnisse - "Rejeski, Kai"

PubPharm (6)

1

Staging of lymphoma under chimeric antigen receptor T-cell therapy : reasons for discordance among imaging response criteria

enthalten in: Cancer imaging : the official publication of the International Cancer Imaging Society | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +10

2

Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria

enthalten in: Cancer imaging | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +10

3

Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +10

4

Functional connectivity MRI provides an imaging correlate for chimeric antigen receptor T-cell-associated neurotoxicity

enthalten in: Neuro-oncology advances | 2023

von Stoecklein, S. | Wunderlich, S. | Papazov, B. | +18

5

Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2022

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +10

6

Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment : RECIL vs. Lugano vs. metabolic tumor assessment

enthalten in: Frontiers in oncology | 2022

von Winkelmann, M. | Bücklein, V. | Blumenberg, V. | +10

1
[1]